Mechanistically, metformin can enhance neuronal bioenergetics, promote nerve repair and reduce toxic protein aggregates in neurological diseases through the activation of AMPK and suppression of the mammalian target of rapamycin (mTOR) pathway (Demaré et al., 2021). The gene discussed is MTOR; the disease is nervous system disorder.